Search Results - "Paolo, Antonello Di"

Refine Results
  1. 1

    Pharmacokinetic drug-drug interaction and their implication in clinical management by Palleria, Caterina, Di Paolo, Antonello, Giofrè, Chiara, Caglioti, Chiara, Leuzzi, Giacomo, Siniscalchi, Antonio, De Sarro, Giovambattista, Gallelli, Luca

    Published in Journal of research in medical sciences (01-07-2013)
    “…Drug-drug interactions (DDIs) are one of the commonest causes of medication error in developed countries, particularly in the elderly due to poly-therapy, with…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid Leukemia by Polillo, Marialuisa, Galimberti, Sara, Baratè, Claudia, Petrini, Mario, Danesi, Romano, Di Paolo, Antonello

    “…Chronic myeloid leukemia was the first haematological neoplasia that benefited from a targeted therapy with imatinib nearly 15 years ago. Since then, several…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The pharmacological bases of the antiangiogenic activity of paclitaxel by Bocci, Guido, Di Paolo, Antonello, Danesi, Romano

    Published in Angiogenesis (London) (01-07-2013)
    “…In the mid 1990s, researchers began to investigate the antiangiogenic activity of paclitaxel as a possible additional mechanism contributing to its…”
    Get full text
    Journal Article
  6. 6

    Personalized Medicine of Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacogenetics, Therapeutic Drug Monitoring, and Beyond by Di Paolo, Antonello, Luci, Giacomo

    Published in Frontiers in pharmacology (08-02-2021)
    “…The pharmacotherapy of inflammatory bowel diseases (Crohn's disease and ulcerative colitis) has experienced significant progress with the advent of monoclonal…”
    Get full text
    Journal Article
  7. 7

    Personalized medicine in Europe: not yet personal enough? by Di Paolo, Antonello, Sarkozy, François, Ryll, Bettina, Siebert, Uwe

    Published in BMC health services research (19-04-2017)
    “…Personalized medicine has the potential to allow patients to receive drugs specific to their individual disease, and to increase the efficiency of the…”
    Get full text
    Journal Article
  8. 8

    Interactions between Food and Drugs, and Nutritional Status in Renal Patients: A Narrative Review by D'Alessandro, Claudia, Benedetti, Alessia, Di Paolo, Antonello, Giannese, Domenico, Cupisti, Adamasco

    Published in Nutrients (04-01-2022)
    “…Drugs and food interact mutually: drugs may affect the nutritional status of the body, acting on senses, appetite, resting energy expenditure, and food intake;…”
    Get full text
    Journal Article
  9. 9

    The CoV-2 outbreak: how hematologists could help to fight Covid-19 by Galimberti, Sara, Baldini, Chiara, Baratè, Claudia, Ricci, Federica, Balducci, Serena, Grassi, Susanna, Ferro, Francesco, Buda, Gabriele, Benedetti, Edoardo, Fazzi, Rita, Baglietto, Laura, Lucenteforte, Ersilia, Di Paolo, Antonello, Petrini, Mario

    Published in Pharmacological research (01-07-2020)
    “…[Display omitted] COVID-19 is a medical emergency, with 20 % of patients presenting with severe clinical manifestations. From the pathogenetic point of view,…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment by Arrigoni, Elena, Del Re, Marzia, Galimberti, Sara, Restante, Giuliana, Rofi, Eleonora, Crucitta, Stefania, Baratè, Claudia, Petrini, Mario, Danesi, Romano, Di Paolo, Antonello

    Published in Stem cells translational medicine (01-03-2018)
    “…Nowadays, more than 90% of patients affected by chronic myeloid leukemia (CML) survive with a good quality of life, thanks to the clinical efficacy of tyrosine…”
    Get full text
    Journal Article
  12. 12

    Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non‐Small Cell Lung Cancer: The Role of Cancer Stem Cells by Del Re, Marzia, Arrigoni, Elena, Restante, Giuliana, Passaro, Antonio, Rofi, Eleonora, Crucitta, Stefania, De Marinis, Filippo, Di Paolo, Antonello, Danesi, Romano

    Published in Stem cells (Dayton, Ohio) (01-05-2018)
    “…Among the potential mechanisms involved in resistance to tyrosine kinase inhibitors (TKIs) in non‐small cell lung cancer, the manifestation of stem‐like…”
    Get full text
    Journal Article
  13. 13

    Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins by Arrigoni, Elena, Del Re, Marzia, Fidilio, Leonardo, Fogli, Stefano, Danesi, Romano, Di Paolo, Antonello

    “…In the era of precision medicine, more attention is paid to the search for predictive markers of treatment efficacy and tolerability. Statins are one of the…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Pharmacokinetics of Non-β-Lactam β-Lactamase Inhibitors by Luci, Giacomo, Mattioli, Francesca, Falcone, Marco, Di Paolo, Antonello

    Published in Antibiotics (Basel) (24-06-2021)
    “…The growing emergence of drug-resistant bacterial strains is an issue to treat severe infections, and many efforts have identified new pharmacological agents…”
    Get full text
    Journal Article
  16. 16

    Association of plasma levetiracetam concentration, MGMT methylation and sex with survival of chemoradiotherapy-treated glioblastoma patients by Cucchiara, Federico, Luci, Giacomo, Giannini, Noemi, Giorgi, Filippo Sean, Orlandi, Paola, Banchi, Marta, Di Paolo, Antonello, Pasqualetti, Francesco, Danesi, Romano, Bocci, Guido

    Published in Pharmacological research (01-07-2022)
    “…Glioblastoma multiforme (GBM) is an aggressive brain tumor, often occurring with seizures managed with antiepileptic drugs, such as levetiracetam (LEV). This…”
    Get full text
    Journal Article
  17. 17

    Precision Medicine in Lymphoma by Innovative Instrumental Platforms by Di Paolo, Antonello, Arrigoni, Elena, Luci, Giacomo, Cucchiara, Federico, Danesi, Romano, Galimberti, Sara

    Published in Frontiers in oncology (17-12-2019)
    “…In recent years, many efforts have been addressed to the growing field of precision medicine in order to offer individual treatments to every patient on the…”
    Get full text
    Journal Article
  18. 18

    Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review—Part I by Finazzi, Stefano, Luci, Giacomo, Olivieri, Carlo, Langer, Martin, Mandelli, Giulia, Corona, Alberto, Viaggi, Bruno, Di Paolo, Antonello

    Published in Antibiotics (Basel) (29-08-2022)
    “…The challenging severity of some infections, especially in critically ill patients, makes the diffusion of antimicrobial drugs within tissues one of the…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Population Pharmacokinetics of Intravenous Acyclovir in Oncologic Pediatric Patients by Maximova, Natalia, Nisticò, Daniela, Luci, Giacomo, Simeone, Roberto, Piscianz, Elisa, Segat, Ludovica, Barbi, Egidio, Di Paolo, Antonello

    Published in Frontiers in pharmacology (14-04-2022)
    “…Acyclovir represents the first-line prophylaxis and therapy for herpes virus infections. However, its pharmacokinetics in children exposes them to the risk of…”
    Get full text
    Journal Article